GOLDMAN SACHS GROUP INC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 78 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,315,000
-26.4%
24,884
-14.6%
0.00%
-100.0%
Q2 2020$1,786,000
-75.9%
29,148
-77.7%
0.00%
-66.7%
Q1 2020$7,401,000
-4.3%
130,838
-3.7%
0.00%
+50.0%
Q4 2019$7,733,000
-4.0%
135,799
-9.8%
0.00%0.0%
Q3 2019$8,057,000
-21.4%
150,536
-12.3%
0.00%
-33.3%
Q2 2019$10,250,000
+1.1%
171,659
+5.6%
0.00%0.0%
Q1 2019$10,137,000
-13.0%
162,632
-15.4%
0.00%
-25.0%
Q4 2018$11,655,000
+108.2%
192,323
+100.9%
0.00%
+300.0%
Q3 2018$5,599,000
+30.8%
95,731
+0.3%
0.00%0.0%
Q2 2018$4,280,000
-9.9%
95,404
-10.9%
0.00%0.0%
Q1 2018$4,750,000
+2.9%
107,122
+0.5%
0.00%0.0%
Q4 2017$4,616,000
-6.1%
106,546
+0.8%
0.00%0.0%
Q3 2017$4,915,000
-12.1%
105,664
-6.4%
0.00%0.0%
Q2 2017$5,589,000
+75.5%
112,894
+94.3%
0.00%0.0%
Q1 2017$3,185,000
+6.2%
58,117
+8.0%
0.00%0.0%
Q4 2016$2,998,000
+47.0%
53,820
+20.5%
0.00%0.0%
Q3 2016$2,040,000
+40.0%
44,662
+22.5%
0.00%
Q2 2016$1,457,000
+23.4%
36,472
+7.5%
0.00%
Q1 2016$1,181,000
-19.4%
33,928
-0.5%
0.00%
Q4 2015$1,465,000
-0.8%
34,084
+0.5%
0.00%
Q3 2015$1,477,000
-15.5%
33,921
+0.1%
0.00%
-100.0%
Q2 2015$1,748,000
+31.8%
33,8720.0%0.00%
Q1 2015$1,326,000
+15.4%
33,872
+13.8%
0.00%
Q4 2014$1,149,000
+209.7%
29,758
+183.2%
0.00%
Q3 2014$371,000
+12.4%
10,508
-37.9%
0.00%
Q3 2013$330,000
+14.6%
16,933
-8.4%
0.00%
Q2 2013$288,00018,4930.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 211,370$9,833,0005.80%
JW Asset Management, LLC 73,649$3,426,0002.51%
NORTHPOINTE CAPITAL LLC 135,657$6,311,0000.67%
Elk Creek Partners, LLC 170,102$7,913,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 156,167$7,265,0000.32%
Ativo Capital Management LLC 22,592$1,051,0000.28%
Matarin Capital Management, LLC 59,077$2,748,262,0000.23%
ISTHMUS PARTNERS, LLC 16,753$779,0000.22%
CADENCE CAPITAL MANAGEMENT LLC 29,586$1,376,0000.09%
ALGERT GLOBAL LLC 7,834$364,0000.08%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders